Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2-Reference-Cited by-同舟云学术

Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2

Published:1997-06 Issue:7 Volume:33 Page:1050-1054
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Engelhardt M

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference14 articles.

1. Biological therapy with interleukin-2: clinical applications;Schwartzentruber,1995

2. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated cells and interleukin-2 or high-dose interleukin-2 alone;Rosenberg;New Engl J Med,1987

3. Constant infusion recombinant interleukin-2 in adoptive immunotherapy of cancer;West;New Engl J Med,1987

4. A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastastic renal cell carcinoma and malignant melanoma;Lindemann;Cancer Immunother,1989

5. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report;Rosenberg;New Engl J Med,1988

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines (IL-2, IFN, GM-CSF, etc.) Melanoma;Cutaneous Melanoma;2020

2. Cytokines (IL-2, IFN GM-CSF etc) Melanoma;Cutaneous Melanoma;2018-10-30

3. Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial;BJU International;2010-09-14

4. Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins;Cancer Immunology, Immunotherapy;2008-10-17

5. Sustained release of bioactive therapeutic proteins from a biodegradable elastomeric device;Journal of Controlled Release;2007-01